Safety data sheet. GHS / OSHA HCS 2012 format, 16 sections. Issued by Epic Peptides Lab for the catalogue items listed in Section 1.

Epic Peptides Lab

Safety data sheet · solution, vial

Epic Peptides Lab · USA

Document number
PL-SDS-081
Revision
1.0 · 2026-10-03

HHB Blend (B-vitamin and lipotropic blend)

solution, vial

WARNING

1Identification

Product Identifier
HHB Blend (B-vitamin and lipotropic blend)
Document Number
PL-SDS-081
Catalogue Items Covered
  • Id
    2904
    Name
    HHB Peptide (Healthy Hair & Nails Blend)
    Sku
    PL-HHB-BLD
Recommended Use
Laboratory research use by trained personnel.
Restrictions On Use
Not for human or veterinary use.
Supplier / Distributor
Epic Peptides Lab, USA
Telephone
+1 (787) 468-5291
Email
info@epicpeptideslab.com

2Hazard(s) identification

Classification
  • Serious eye damage/eye irritation — Category 2A — H319
Label Elements
Pictograms
  • GHS07
Signal
Warning
Hazard statements
  • H319 Causes serious eye irritation.
Precautionary statements
  • P264 Wash hands and any exposed skin thoroughly after handling.
  • P280 Wear protective gloves, protective clothing and eye protection.
  • P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
  • P337+P313 If eye irritation persists: Get medical advice/attention.
Signal Word
Warning
Other Hazards
No data available.

3Composition / information on ingredients

Description
Sterile aqueous solution in a sealed multi-dose glass vial with a rubber stopper.
Composition
  • Name
    Niacinamide
    Full
    Nicotinamide (vitamin B3)
    Cas
    98-92-0
    Formula
    C6H6N2O
    Conc
    5% w/v
    Qty
    500 mg per 10 mL vial
    Hazards
    • Serious eye damage/eye irritation — Category 2A — H319
  • Name
    Thiamine HCl
    Full
    Thiamine hydrochloride (vitamin B1)
    Cas
    67-03-8
    Formula
    C12H18Cl2N4OS
    Conc
    5% w/v
    Qty
    500 mg per 10 mL vial
    Hazards
    • Serious eye damage/eye irritation — Category 2A — H319
  • Name
    Pantothenic acid
    Full
    D-Pantothenic acid / dexpanthenol (vitamin B5)
    Cas
    79-83-4
    Formula
    C9H17NO5
    Conc
    2.5% w/v
    Qty
    250 mg per 10 mL vial
  • Name
    Choline
    Full
    Choline (as chloride or bitartrate)
    Cas
    67-48-1
    Formula
    C5H14ClNO
    Conc
    1% w/v
    Qty
    100 mg per 10 mL vial
  • Name
    Inositol
    Full
    myo-Inositol
    Cas
    87-89-8
    Formula
    C6H12O6
    Conc
    1% w/v
    Qty
    100 mg per 10 mL vial
  • Name
    Niacin
    Full
    Nicotinic acid (vitamin B3)
    Cas
    59-67-6
    Formula
    C6H5NO2
    Conc
    0.5% w/v
    Qty
    50 mg per 10 mL vial
    Hazards
    • Serious eye damage/eye irritation — Category 2A — H319
  • Name
    Biotin
    Full
    D-Biotin (vitamin B7)
    Cas
    58-85-5
    Formula
    C10H16N2O3S
    Conc
    0.01% w/v
    Qty
    1 mg per 10 mL vial
  • Name
    Folic acid
    Full
    Folic acid (vitamin B9)
    Cas
    59-30-3
    Formula
    C19H19N7O6
    Conc
    0.01% w/v
    Qty
    1 mg per 10 mL vial
  • Name
    Riboflavin
    Full
    Riboflavin (vitamin B2) / riboflavin 5-phosphate
    Cas
    83-88-5
    Formula
    C17H20N4O6
    Conc
    0.01% w/v
    Qty
    1 mg per 10 mL vial
  • Name
    Water for injection
    Full
    Water for injection
    Cas
    7732-18-5
    Formula
    H2O
    Conc
    balance to 100%

4First-aid measures

First Aid Measures
Inhalation
Move the person to fresh air and keep comfortable for breathing. If breathing is difficult or symptoms persist, call a POISON CENTER or doctor.
Skin
Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice.
Eyes
Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice.
Ingestion
Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.
Injection
For an accidental needle-stick: wash the site with soap and water, do not squeeze, cover with a dressing and seek medical advice; report the incident according to your laboratory's sharps procedure.
Most Important Symptoms And Effects
eye redness, watering and irritation.
Likely Routes Of Exposure
Skin and eye contact from splashes; accidental injection with needles used to withdraw the solution; ingestion.

5Fire-fighting measures

Fire Fighting Information
Aqueous solution; not flammable and does not support combustion.

6Accidental release measures

Spill And Clean Up Procedures
Absorb small spills with paper towel or an inert absorbent, place in a sealed container for disposal and clean the area with water and detergent.

7Handling and storage

Safe Handling
Use aseptic technique when withdrawing solution. Avoid splashes to eyes and skin. Do not pipette by mouth. Wash hands after handling.
Safe Storage
Store at 2–8 °C, protected from light; do not freeze. Keep the vial upright and tightly closed.
Storage Temperature
2–8 °C, protected from light; do not freeze
Incompatible Materials
reducing agents; metals; iodine; sulfides; mercury compounds; Acids; alkalis; Spectrum: none known; nitrous acid; formaldehyde; reducing agents; reducing agents; calcium and metallic salts

8Exposure controls / personal protection

Occupational Exposure Limits
No data available.
Exposure Controls And PPE
No data available.

9Physical and chemical properties

Physical State
Liquid
Appearance
Clear, yellow aqueous solution (B vitamins)
Properties
Odor
Odourless
Ph
Approximately 5–7
Melting
About 0 °C (aqueous solution)
Boiling
About 100 °C (aqueous solution)
Flash
Not flammable; aqueous solution
Vapour
As water (about 2.3 kPa at 20 °C)
Density
About 1.00–1.02 g/mL at 20 °C
Solubility
Aqueous solution; miscible with water
Logp
-0.38
Decomp
Not applicable (aqueous solution); dissolved peptide degrades on heating

10Stability and reactivity

Stability And Reactivity
Reactivity
Chemically stable at room temperature; may form combustible/explosive dust mixtures with air when finely divided
Incompatible
Strong oxidizing agents (Sigma); strong acids, strong bases (MakingCosmetics)
Decomposition
Carbon oxides, nitrogen oxides (NOx)
Conditions To Avoid
Strong heating; dust formation; light and moisture for long-term storage
Conditions To Avoid
Strong heating; dust formation; light and moisture for long-term storage; Exposure to light or heat may cause decomposition (Lupin); moisture (hygroscopic); alkaline conditions (thiamine is unstable above pH ~5.5); Heat; exposure to moisture/moist air (hygroscopic); extremes of pH (hydrolysis); ligh
Incompatible Materials
reducing agents; metals; iodine; sulfides; mercury compounds; Acids; alkalis; Spectrum: none known; nitrous acid; formaldehyde; reducing agents; reducing agents; calcium and metallic salts

11Toxicological information

Toxicological Information
  • Acute toxicity, oral

    LD50 oral rat > 2,500 mg/kg (Sigma); LD50 oral rat 3,500 mg/kg (CIL); LD50 subcutaneous rat 1,680 mg/kg (Cayman kit SDS)

  • Acute toxicity, dermal

    LD50 dermal rabbit > 2,000 mg/kg (Sigma)

  • Acute toxicity, inhalation

    LC50 inhalation rat > 3.8 mg/L (Sigma)

  • Skin corrosion/irritation

    Not irritating (Sigma); CIL (d4 analog) classifies Skin Irrit. 2

  • Serious eye damage/irritation

    Eye irritation — positive (Sigma; basis for H319)

  • Respiratory or skin sensitisation

    Negative in guinea pig maximization test

  • Germ cell mutagenicity

    Negative (Ames, mammalian cell, in vivo micronucleus)

  • Carcinogenicity

    Not listed by IARC, NTP, OSHA

  • Reproductive toxicity

    No data available

  • STOT, single exposure

    No data available (CIL d4 analog: STOT SE 3, respiratory irritation)

  • STOT, repeated exposure

    No data available

  • Aspiration hazard

    No data available

Routes Of Exposure
Skin and eye contact from splashes; accidental injection with needles used to withdraw the solution; ingestion.
Symptoms
eye redness, watering and irritation.

12Ecological information

Ecological Information
Fish LC50 > 1,000 mg/L (96 h); algae NOEC 560 mg/L (72 h); microorganism NOEC 4,235 mg/L; readily biodegradable (96% in 14 d); not bioaccumulative; not PBT/vPvB (Sigma).

13Disposal considerations

Disposal Guidance
No data available.

14Transport information

Transport Classification
Note
Not regulated as a dangerous good for transport by road (DOT 49 CFR), air (IATA/ICAO) or sea (IMDG). Not a marine pollutant. Ship refrigerated or frozen as required by Section 7; the coolant (dry ice, UN 1845) is regulated when used.

15Regulatory information

Regulatory Information
Tsca
Listed (active) on TSCA inventory
Carcinogen Listings
Not listed by IARC, NTP, OSHA; not Prop 65
Dea
Not a controlled substance
Other
SARA 313: Cayman kit SDS flags nicotinamide under EPA TRI category N503 (nitrate/nitrogen compound list) — verify; most SDSs state no SARA 313 listing. Transport: not regulated. FDA GRAS nutrient. Not WADA prohibited.
Carcinogen Listings
No data available.

16Other information

Revision
October 3, 2026
Sources Consulted
  • Sigma-Aldrich / Merck
  • MakingCosmetics Inc.
  • Cambridge Isotope Laboratories
  • Cayman Chemical
  • Sigma-Aldrich
  • Sigma-Aldrich SDS
  • Chemos GmbH
  • Fisher Scientific
  • Lupin Pharmaceuticals
  • DSM Nutritional Products
  • Spectrum Chemical
  • Merck Life Science / Sigma-Aldrich
Confidence
high
Additional Information
No data available.
Back to SDS list
JOIN THE Epic Peptides Lab
Exclusive access for verified researchers only.

Enter your details to access our catalog, COA library,
and research compound database.

By submitting you agree to receive email communications from Epic Peptides Lab You can unsubscribe at any time. All products for in vitro research use only.

15% off any order

Restock alerts, new compounds and fresh lab results.
We’ll email your code straight away – 15% off, one-time use.

Research updates only. Unsubscribe any time.